183 related articles for article (PubMed ID: 37907224)
1. Post-Stroke Spastic Movement Disorder and Botulinum Toxin A Therapy: Early Detection And Early Injection.
Wissel J; Kivi A
Ann Rehabil Med; 2023 Oct; 47(5):326-336. PubMed ID: 37907224
[TBL] [Abstract][Full Text] [Related]
2. Assessment, goal setting, and botulinum neurotoxin a therapy in the management of post-stroke spastic movement disorder: updated perspectives on best practice.
Wissel J; Ri S
Expert Rev Neurother; 2022 Jan; 22(1):27-42. PubMed ID: 34933648
[TBL] [Abstract][Full Text] [Related]
3. Early versus late injections of Botulinumtoxin type A in post-stroke spastic movement disorder: A literature review.
Wissel J; Ri S; Kivi A
Toxicon; 2023 Jun; 229():107150. PubMed ID: 37146733
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.
Dong Y; Wu T; Hu X; Wang T
Eur J Phys Rehabil Med; 2017 Apr; 53(2):256-267. PubMed ID: 27834471
[TBL] [Abstract][Full Text] [Related]
5. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity.
Demetrios M; Khan F; Turner-Stokes L; Brand C; McSweeney S
Cochrane Database Syst Rev; 2013 Jun; (6):CD009689. PubMed ID: 23740539
[TBL] [Abstract][Full Text] [Related]
6. [Improvement of the treatment of patients with spastic movement disorder after stroke].
Lee JI; Günther A; Paus S; Royl G; Weyen U; Wissel J; Zeuner KE; Klebe S
Nervenarzt; 2024 Feb; 95(2):133-140. PubMed ID: 37987799
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Assessment of the Time Course of Biomechanical, Electrophysiological and Neuro-Motor Effects after Botulinum Toxin Injections in Elbow Flexors of Chronic Stroke Survivors with Spastic Hemiplegia: A Cross Sectional Observation Study.
Chen YT; Liu Y; Zhang C; Magat E; Zhou P; Zhang Y; Li S
Toxins (Basel); 2022 Jan; 14(2):. PubMed ID: 35202132
[TBL] [Abstract][Full Text] [Related]
8. Real-world analysis of botulinum toxin (BoNT) injections in post-stroke spasticity: Higher doses of BoNT and longer intervals in the early-start group.
Woo J; Mas MF; Zhang J; Wong B; Stampas A; Francisco GE; Li S
J Neurol Sci; 2021 Jun; 425():117449. PubMed ID: 33878656
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy.
Blumetti FC; Belloti JC; Tamaoki MJ; Pinto JA
Cochrane Database Syst Rev; 2019 Oct; 10(10):CD001408. PubMed ID: 31591703
[TBL] [Abstract][Full Text] [Related]
10. A practical guide to botulinum neurotoxin treatment of shoulder spasticity 1: Anatomy, physiology, and goal setting.
Jacinto J; Camões-Barbosa A; Carda S; Hoad D; Wissel J
Front Neurol; 2022; 13():1004629. PubMed ID: 36324373
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Botulinum Toxin Injections on Spasticity and Motor Performance in Chronic Stroke with Spastic Hemiplegia.
Chen YT; Zhang C; Liu Y; Magat E; Verduzco-Gutierrez M; Francisco GE; Zhou P; Zhang Y; Li S
Toxins (Basel); 2020 Jul; 12(8):. PubMed ID: 32751970
[TBL] [Abstract][Full Text] [Related]
12. Is spastic muscle echo intensity related to the response to botulinum toxin type A in patients with stroke? A cohort study.
Picelli A; Bonetti P; Fontana C; Barausse M; Dambruoso F; Gajofatto F; Girardi P; Manca M; Gimigliano R; Smania N
Arch Phys Med Rehabil; 2012 Jul; 93(7):1253-8. PubMed ID: 22502807
[TBL] [Abstract][Full Text] [Related]
13. A practical guide to botulinum neurotoxin treatment of shoulder spasticity 2: Injection techniques, outcome measurement scales, and case studies.
Wissel J; Camões-Barbosa A; Carda S; Hoad D; Jacinto J
Front Neurol; 2022; 13():1022549. PubMed ID: 36570447
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin for subacute/chronic neck pain.
Langevin P; Peloso PM; Lowcock J; Nolan M; Weber J; Gross A; Roberts J; Goldsmith CH; Graham N; Burnie SJ; Haines T
Cochrane Database Syst Rev; 2011 Jul; (7):CD008626. PubMed ID: 21735434
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with repetitive facilitative exercise program and botulinum toxin type A to improve motor function for the upper-limb spastic paresis in chronic stroke: A randomized controlled trial.
Hokazono A; Etoh S; Jonoshita Y; Kawahira K; Shimodozono M
J Hand Ther; 2022; 35(4):507-515. PubMed ID: 33820711
[TBL] [Abstract][Full Text] [Related]
16. Local muscle injection of botulinum toxin type a synergistically improves the beneficial effects of repetitive transcranial magnetic stimulation and intensive occupational therapy in post-stroke patients with spastic upper limb hemiparesis.
Yamada N; Kakuda W; Kondo T; Mitani S; Shimizu M; Abo M
Eur Neurol; 2014; 72(5-6):290-8. PubMed ID: 25323412
[TBL] [Abstract][Full Text] [Related]
17. Early Use of Phenol Neurolysis Likely Reduces the Total Amount of Botulinum Toxin in Management of Post-Stroke Spasticity.
Li S; Woo J; Mas MF
Front Rehabil Sci; 2021; 2():729178. PubMed ID: 36188807
[TBL] [Abstract][Full Text] [Related]
18. The effect of botulinum toxin injections on gait control in spastic stroke patients presenting with a stiff-knee gait.
Bleyenheuft C; Cockx S; Caty G; Stoquart G; Lejeune T; Detrembleur C
Gait Posture; 2009 Aug; 30(2):168-72. PubMed ID: 19442523
[TBL] [Abstract][Full Text] [Related]
19. [Treatment goals in patients with post-stroke upper limb spasticity following injection of botulinum toxin A : Results of the German-Austrian subgroup of the ULIS-II study].
Fheodoroff K; Dressler D; Woldag H; Koßmehl P; Koch M; Maisonobe P; Reichel G
Nervenarzt; 2019 Apr; 90(4):361-370. PubMed ID: 30324541
[TBL] [Abstract][Full Text] [Related]
20. Isokinetic assessment of the effects of botulinum toxin injection on spasticity and voluntary strength in patients with spastic hemiparesis.
Hameau S; Bensmail D; Robertson J; Boudarham J; Roche N; Zory R
Eur J Phys Rehabil Med; 2014 Oct; 50(5):515-23. PubMed ID: 24651151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
